covid-19 concerns re-surface: what can this translate into for pharma? : vishal manchanda exclusive
Published 1 year ago • 269 plays • Length 5:50Download video MP4
Download video MP3
Similar videos
-
8:58
what to expect from the pharma sector in q4? : systematix group's vishal manchanda exclusive
-
6:01
what is the effect of ranitidine dispute settlement on indian pharma? vishal manchanda reacts
-
12:58
why economic recovery may depend on a coronavirus treatment
-
5:32
the typical progression of covid-19 virus
-
10:11
sanford bernstein's nithya balasubramanian's take on pharma stocks amid covid-19 concerns
-
31:55
everything about coronavirus | covid-19 explained | the dr binocs show | peekaboo kidz
-
50:43
what covid-19 variants could mean for vaccines
-
13:44
how domino’s won india’s pizza wars
-
2:54
health-care analyst explains how big pharma is approaching coronavirus crisis
-
1:00
who’s science in 5 on covid -19: medical waste #shorts
-
1:51
triple-mutant covid variant from india is now a potential global health risk
-
5:39
do variants of the covid virus mean we’ll need more vaccines?
-
14:51
232 - the covid-19 variants explained
-
3:45
who's science in 5 on covid-19: what's long covid and treatment options
-
5:27
who's science in 5 - covid-19: why are experts concerned about omicron? - 21 january 2022
-
5:46
divi's laboratories q3 profit after tax drops 66% yoy to ₹307 crore: vishal manchanda exclusive
-
9:59
why is pharma sector in pain? | a. vaidheesh and vishal manchanda discuss
-
12:59
hydroxychloroquine: can it prevent or treat covid-19 in healthcare workers? | dr. ravi amaravadi
-
5:29
who's science in 5 on covid-19: vaccines, virus variants and doses
-
2:28
dengue patients at higher risk of long-term complications than covid patients: ntu study
-
2:06
dr. fauci recovering after being hospitalized with west nile virus
-
1:27
what you need to know about coronavirus